Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma

Journal of Pathology

Volumn 187, Issue 4, 1999, Pages 439-445

  Tannapfel, Andrea ^b   Geissler, Felix ^b   Köckerling, Ferdinand ^b   Katalinic, Alexander ^b   Hauss, Johann ^b   Wittekind, Christian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

Apoptosis; Hepatocellular carcinoma; Histopathological parameters; Prognosis; Proliferation markers

Indexed keywords

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MITOSIS INDEX; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROGNOSIS;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; FEMALE; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOTIC INDEX; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033053671     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199903)187:4<439::AID-PATH272>3.0.CO;2-B     Document Type: Article

References (24)

1. Wittekind Ch. Hepatocellular carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH, eds. Prognostic Factors in Cancer. Berlin: Springer-Verlag, 1995: 88-93.
2. Ringe B, Pichlmayr R, Wittekind Ch, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-285.
3. Matthew J, Hines JE, Obafunwa JO, Burr AW, Toole K, Burt AD. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol 1996; 19: 74-79.
4. Abou-Elella A, Gramlich T, Fritsch Ch, Gansler T. c-myc amplification in hepatocellular carcinoma predicts unfavourable prognosis. Mod Pathol 1996; 9: 95-98.
5. Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N. Sugimachi K. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 1995; 76: 399-405.
6. Rosellini SR, Arienti V, Nanni O, et al. Hepatocellular carcinoma: prognostic factors and survival analysis in 135 Italian patients. J Hepatol 1992; 16: 66-72.
7. Soini Y, Virkajarvi N, Lehto VP, Paako P. Hepatocellular carcinomas with a high proliferation index and a low segree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 1996; 73: 1025-1030.
8. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer 1954; 7: 462-503.
9. Ishak T (ed.). WHO: Histological Typing of Tumours of the Liver. 2nd edn. Berlin: Springer-Verlag, 1994.
10. Sobin LH, Wittekind Ch (ed.). UICC: TNM Classification of Malignant Tumors. 5th edn. New York: Wiley-Liss, 1997.
11. Tannapfel A, Hahn H, Katalinic A, Fietkau R, Kühn R, Wittekind Ch. Incidence of apoptosis, cell proliferation and p53 expression in renal cell carcinoma. Anticancer Res 1997; 17: 1155-1162.
12. Aubele M, Biesterfeld S, Derenzini M, et al. Guidelines of AgNOR quantitation. Zentralbl Pathol 1994; 140: 107-108.
13. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8.
14. Dervan PA, Gilmartin LG, Loftus BM, Carney DN. Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki-67 scores. Am J Clin Pathol 1989; 92: 401-407.
15. Hall PA, Crocker J, Watts A, Stansfeld AG. A comparison of nucleolar organizer region staining and Ki67 immunostaining in non-Hodgkin's lymphoma. Histopathology 1988; 12: 373-381.
16. Grigioni WF, Dèrrico A, Bacci F, et al. Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67. J Pathol 1989; 158: 23-29.
17. Delhaye M, Louis H, Degraef C, et al. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology 1996; 23: 1003-1011.
18. Nagao T, Ishida Y, Yamazaki K, Kondo Y. Nucleolar organizer regions in hepatocellular carcinoma are related to the cell cycle, cell proliferation and histologic grade. Pathol Res Pract 1995; 191: 967-972.
19. Trere D, Gramantieri L, Siringo S, Melchiorri C, Barbara L, Derenzini M. In hepatocellular carcinoma AgNOR protein expression correlates with tumour mass doubling time. J Hepatol 1996; 24: 60-65.
20. Columbano A, Ledda-Columbano GM, Rao PM, Rajalakshmi S, Sarma DSR. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. Am J Pathol 1984; 116: 441-446.
21. Hino N, Higashi T, Nouso K, Nakatsukasa H, Tsuji T. Apoptosis and proliferation of human hepatocellular carcinoma. Liver 1996; 16: 123-129.
22. Ng IOL, Lai ECS, Fan ST, Ng NMT, So MKP. Prognostic significance of pathologic features of hepatocellular carcinoma. Cancer 1995; 76: 2443-2448.
23. Nzeako U, Goodman ZD, Ishak KG. Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 1995; 76: 579-588.
24. Zhao G, Su S, Borek D, Friesen S, Halmes F. Long survival and prognostic factors in hepatocellular carcinoma. J Surg Oncol 1990; 45: 257-260.